All news

An officer's proposed sale covers 15,286 Vertex Pharmaceuticals (VRTX) shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Charles F. Wagner Jr., an officer at Vertex Pharmaceuticals Inc. (VRTX), has proposed selling 15,286 common shares, valued at approximately $8.37 million, with an anticipated sale date of November 12, 2026. The shares were acquired through ESPP purchases and restricted stock vesting between November 2023 and May 2025.

Read original source

VRTX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.